Actuate Therapeutics ACTU
NASDAQ ACTU
$0.30 -0.01 (-3.23%)
At close: Nov 10, 2026 · 4:00 PM EST

Actuate Therapeutics (ACTU) Preferred Stock Liabilities (2023 - 2024)

Updated

Actuate Therapeutics (ACTU) reported Preferred Stock Liabilities of $94.18 million for Q2 2024.

Analysis

Actuate Therapeutics (ACTU) Preferred Stock Liabilities (2023 - 2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn -
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn -
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn -
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn -
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn -
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn -
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn -
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn -
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn -
10 Actuate Therapeutics 7.56 Mn -35.08 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 94.18 Mn
Dec 31, 2023 94.18 Mn
API Access

Actuate Therapeutics Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=ACTU&period=max&api_key=YOUR_API_KEY